Using a loss-of-function assay, we assess the effects of MTA2 depletion on osteosarcoma cell metastasis in vitro and in vivo with the goal of determining whether MTA2 is a potential therapeutic target for osteosarcoma. The gene discussed is MTA2; the disease is osteosarcoma.